Cargando…
Aldehyde Dehydrogenases and Prostate Cancer: Shedding Light on Isoform Distribution to Reveal Druggable Target
Prostate cancer represents the most common malignancy diagnosed in men, and is the second-leading cause of cancer death in this population. In spite of dedicated efforts, the current therapies are rarely curative, requiring the development of novel approaches based on innovative molecular targets. I...
Autores principales: | Quattrini, Luca, Sadiq, Maria, Petrarolo, Giovanni, Maitland, Norman J., Frame, Fiona M., Pors, Klaus, La Motta, Concettina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761903/ https://www.ncbi.nlm.nih.gov/pubmed/33291762 http://dx.doi.org/10.3390/biomedicines8120569 |
Ejemplares similares
-
Expansion of the
4-(Diethylamino)benzaldehyde
Scaffold to Explore the Impact on Aldehyde Dehydrogenase Activity
and Antiproliferative Activity in Prostate Cancer
por: Ibrahim, Ali I. M., et al.
Publicado: (2022) -
A Selective Competitive Inhibitor of Aldehyde Dehydrogenase 1A3 Hinders Cancer Cell Growth, Invasiveness and Stemness In Vitro
por: Gelardi, Edoardo L. M., et al.
Publicado: (2021) -
Pharos: Collating protein information to shed light on the druggable genome
por: Nguyen, Dac-Trung, et al.
Publicado: (2017) -
Aurones: A Golden Resource for Active Compounds
por: Mazziotti, Ilaria, et al.
Publicado: (2021) -
Emerging Roles of Aldehyde Dehydrogenase Isoforms in Anti-cancer Therapy Resistance
por: Zanoni, Michele, et al.
Publicado: (2022)